Skip to main content
Watch Insiders
BEAMHealthcare

Beam Therapeutics Inc (BEAM) Insider Trading

In the last 90 days, 2 Beam Therapeutics Inc (BEAM) insiders reported no open-market purchases and 2 sales totaling $1,193,310. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Oct 16, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 16, 2026John M. EvansCEOSale50,000$23.77$1,188,745
Oct 1, 2026Bethany J CavanaghSVP, Finance and TreasurerSale187$24.41$4,565
Jul 27, 2026Amy SimonChief Medical OfficerSale16,667$25.74$429,037
Jun 30, 2026Amy SimonChief Medical OfficerSale373$34.73$12,954
Jun 30, 2026John M. EvansCEOSale50,000$34.90$1,745,035
Jun 26, 2026Fmr LLC10% OwnerSale284,860$35.24$10,039,492

Common questions

BEAM insider trading FAQ

Are BEAM insiders buying or selling?
Over the last 90 days, BEAM insiders were net sellers, reporting $0.00 of open-market purchases and $1,193,310 of sales.
When was the last BEAM insider purchase?
No open-market insider purchase of Beam Therapeutics Inc stock was reported in the last 90 days.
Where does BEAM insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Beam Therapeutics Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.